Literature DB >> 1756548

Urokinase thrombolysis using a multiple side hole multilumen infusion catheter.

S L Kaufman1, L G Martin, B P Gilarsky, M F Finnegan, W J Casarella.   

Abstract

A multilumen, multiple side hole infusion catheter was used for urokinase thrombolysis in 13 patients with thromboembolic occlusions of peripheral arteries and grafts. Balloon angioplasty was performed following urokinase infusion in 6 patients and atherectomy in 1 patient. There was one hemorrhagic complication. The major advantage of the multiple sidehole infusion catheter was the elimination of the need to reposition the catheter during the infusion and the reduction of the time burden on the angiographic facility. The success rate for the thrombolysis (77%) was comparable to results recorded in the literature. The total duration of infusion was not reduced compared to other series.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1756548     DOI: 10.1007/bf02577891

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  11 in total

1.  Thrombolysis with recombinant human tissue-type plasminogen activator in patients with peripheral artery and bypass graft occlusions.

Authors:  R A Graor; B Risius; F V Lucas; J R Young; W F Ruschhaupt; E G Beven; E B Grossbard
Journal:  Circulation       Date:  1986-09       Impact factor: 29.690

2.  Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial.

Authors:  M F Meyerovitz; S Z Goldhaber; K Reagan; J F Polak; K Kandarpa; C J Grassi; B C Donovan; M A Bettmann; D P Harrington
Journal:  Radiology       Date:  1990-04       Impact factor: 11.105

3.  Salvage of occluded arterial bypass grafts by means of thrombolysis.

Authors:  G A Gardiner; D P Harrington; W Koltun; A Whittemore; J A Mannick; D C Levin
Journal:  J Vasc Surg       Date:  1989-03       Impact factor: 4.268

4.  Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase.

Authors:  T O McNamara; J R Fischer
Journal:  AJR Am J Roentgenol       Date:  1985-04       Impact factor: 3.959

5.  Technique and results of "low-dose" infusion.

Authors:  B T Katzen
Journal:  Cardiovasc Intervent Radiol       Date:  1988       Impact factor: 2.740

6.  Thrombolytic therapy with recombinant human tissue-type plasminogen activator: a comparison of two doses.

Authors:  B Risius; R A Graor; M A Geisinger; M G Zelch; F V Lucas; J R Young
Journal:  Radiology       Date:  1987-08       Impact factor: 11.105

7.  Recombinant human tissue-type plasminogen activator is an effective agent for thrombolysis of peripheral arteries and bypass grafts: preliminary report.

Authors:  W C Krupski; R K Feldman; J H Rapp
Journal:  J Vasc Surg       Date:  1989-11       Impact factor: 4.268

8.  Thrombolysis of occluded femoropopliteal grafts.

Authors:  G A Gardiner; W Koltun; K Kandarpa; A Whittemore; M F Meyerovitz; M A Bettmann; D C Levin; D P Harrington
Journal:  AJR Am J Roentgenol       Date:  1986-09       Impact factor: 3.959

9.  Thrombolytic therapy in acute arterial thrombosis.

Authors:  C Price; M A Jacocks; T Tytle
Journal:  Am J Surg       Date:  1988-12       Impact factor: 2.565

10.  Two urokinase dose regimens in native arterial and graft occlusions: initial results of a prospective, randomized clinical trial.

Authors:  A H Cragg; T P Smith; J D Corson; N Nakagawa; F Castaneda; T F Kresowik; W J Sharp; A Shamma; K S Berbaum
Journal:  Radiology       Date:  1991-03       Impact factor: 11.105

View more
  2 in total

1.  Local intraarterial thrombolysis: in vitro comparison between automatic and manual pulse-spray infusion.

Authors:  J J Froelich; C Freymann; M Hoppe; T Thiel; H J Wagner; K H Barth; K J Klose
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Nov-Dec       Impact factor: 2.740

2.  Crossover approach with a J-shaped sheath for angioplasty of iliofemoral artery stenoses and occlusions.

Authors:  K Kichikawa; H Uchida; K Nishimine; M Maeda; Y Kubota; H Ohishi
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Mar-Apr       Impact factor: 2.740

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.